Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1962 Apr;18(2):255–274. doi: 10.1111/j.1476-5381.1962.tb01406.x

Pharmacological actions of pepsitensin

A M J N Blair
PMCID: PMC1482117  PMID: 13869728

Abstract

In confirmation of the results of Croxatto and his co-workers, plasma proteins incubated with pepsin yielded a substance (pepsitensin) with pressor activity. Euglobulin gave a much higher yield than the other plasma protein fractions. Incubation for 4 hr at pH 4 gave high yields of pressor activity (pepsitensin) but no antidiuretic activity; incubation of euglobulin for 4 hr at pH 2.5 yielded extracts with antidiuretic as well as pressor activity. Incubation for 8 to 11 hr at pH 2.5 produced the highest yield of both activities. Further incubation, at the same pH, up to 20 hr caused a rapid decline in the pressor activity of the extracts, but the antidiuretic activity was much more resistant to destruction by pepsin. Pepsitensin was found to be very soluble in water and poorly soluble in organic solvents. It is not inactivated by thioglycollate. In blood pressure assays some animals did not respond to pepsitensin, and nephrectomized (17 to 24 hr) rats were found to be more suitable preparations. Pepsitensin was shown to exert pressor effect by direct action on the blood vessels. Its pressor action could be differentiated from that of tyramine, dimethylphenylpiperazine, nicotine, noradrenaline and Pitressin but not from that of angiotensin. The isolated guinea-pig ileum and the rat uterus were equally sensitive to angiotensin and pepsitensin. In paper chromatograms, in the solvent system butanol-acetic acid-water, the RF of pepsitensin was very similar to that of angiotensin.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMES R. G., VAN DYKE H. B. Thioglycollate inactivation of posterior pituitary antidiuretic principle as determined in the rat. Proc Soc Exp Biol Med. 1951 Mar;76(3):576–578. doi: 10.3181/00379727-76-18563. [DOI] [PubMed] [Google Scholar]
  2. BRAUN-MENENDEZ E., PALADINI A. C. Pressor polypeptides formed in vivo and in vitro as mediators of renal hypertension. Circulation. 1958 Apr;17(4 Pt 2):668–671. doi: 10.1161/01.cir.17.4.668. [DOI] [PubMed] [Google Scholar]
  3. BUMPUS F. M., GREEN A. A., PAGE I. H. Purification of angiotonin. J Biol Chem. 1954 Sep;210(1):287–294. [PubMed] [Google Scholar]
  4. BURN J. H., RAND M. J. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958 Dec 4;144(2):314–336. doi: 10.1113/jphysiol.1958.sp006104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braun-Menendez E., Fasciolo J. C., Leloir L. F., Muñoz J. M. The substance causing renal hypertension. J Physiol. 1940 Jul 24;98(3):283–298. doi: 10.1113/jphysiol.1940.sp003850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COLLINS D. A., HARAKAL C. D. Changes in hypertensinase and hypertensinogen following nephrectomy. Circ Res. 1954 May;2(3):196–200. doi: 10.1161/01.res.2.3.196. [DOI] [PubMed] [Google Scholar]
  7. CROXATTO H., PEREDA T., MELLADA R. Peptides with oxytocic and pressor activity obtained from acidified rat serum. Nature. 1959 Nov 7;184(Suppl 19):1496–1496. doi: 10.1038/1841496a0. [DOI] [PubMed] [Google Scholar]
  8. CROXATTO H., ROJAS G., BARNAFI L. An antidiuretic substance obtained by digestion of globulin with pepsin. Science. 1951 Apr 27;113(2939):494–495. doi: 10.1126/science.113.2939.494. [DOI] [PubMed] [Google Scholar]
  9. CROXATTO H., ROJAS G., BARNAFI L. The liberation of an anti-diuretic factor by the hypertensinogen pepsin reaction. Acta Physiol Lat Am. 1951 Jul;1(3):178–186. [PubMed] [Google Scholar]
  10. Croxatto H., Croxatto R. "PEPSITENSIN"--A HYPERTENSINLIKE SUBSTANCE PRODUCED BY PEPTIC DIGESTION OF PROTEINS. Science. 1942 Jan 23;95(2456):101–102. doi: 10.1126/science.95.2456.101. [DOI] [PubMed] [Google Scholar]
  11. DEKANSKI J. The quantitative assay of vasopressin. Br J Pharmacol Chemother. 1952 Dec;7(4):567–572. doi: 10.1111/j.1476-5381.1952.tb00723.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DENGLER H. Untersuchungen über Pepsitensin. Z Gesamte Exp Med. 1956;127(2):153–159. [PubMed] [Google Scholar]
  13. GADDUM J. H., HAMEED K. A., HATHWAY D. E., STEPHENS F. F. Quantitative studies of antagonists for 5-hydroxytryptamine. Q J Exp Physiol Cogn Med Sci. 1955 Jan;40(1):49–74. doi: 10.1113/expphysiol.1955.sp001097. [DOI] [PubMed] [Google Scholar]
  14. GADDUM J. H. Simplified mathematics for bioassays. J Pharm Pharmacol. 1953 Jun;5(6):345–358. doi: 10.1111/j.2042-7158.1953.tb13996.x. [DOI] [PubMed] [Google Scholar]
  15. GINSBURG M., HELLER H. The antidiuretic assay of vasopressin by intravenous injection into unanaesthetized rats. J Endocrinol. 1953 Jul;9(3):267–273. doi: 10.1677/joe.0.0090267. [DOI] [PubMed] [Google Scholar]
  16. GROSS F., LICHTLEN P. Verstärkung der pressorischen Wirkung von Renin, drucksteigernden Peptiden und adrenergischen Wirkstoffen nach Nephrektomie und bei Uberdosierung von Cortexon und Kochsalz an der Ratte. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;233(4):323–337. [PubMed] [Google Scholar]
  17. GROSS F. Renin und Hypertensin, physiologische oder pathologische Wirkstoffe? Klin Wochenschr. 1958 Aug 1;36(15):693–706. doi: 10.1007/BF01493136. [DOI] [PubMed] [Google Scholar]
  18. HELLER H., PICKERING B. T. Neurohypophysial hormones of non-mammalian vertebrates. J Physiol. 1961 Jan;155:98–114. doi: 10.1113/jphysiol.1961.sp006616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. HELMER O. M. A simple chromatographic procedure for the separation of angiotonin from crude mixtures. Proc Soc Exp Biol Med. 1950 Jul;74(3):642–644. doi: 10.3181/00379727-74-18002. [DOI] [PubMed] [Google Scholar]
  20. KARP D., RINZLER S. H., TRAVELL J. Effects of ergometrine (ergonovine) on the isolated atherosclerotic heart of the cholsterol-fed rabbit. Br J Pharmacol Chemother. 1960 Jun;15:333–344. doi: 10.1111/j.1476-5381.1960.tb01253.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McCUBBIN J. W., PAGE I. H. Renal inhibition of pressor responses to drugs. Circ Res. 1954 Jan;2(1):35–40. doi: 10.1161/01.res.2.1.35. [DOI] [PubMed] [Google Scholar]
  22. PEART W. S. A new method of large-scale preparation of hypertensin, with a note on its assay. Biochem J. 1955 Feb;59(2):300–302. doi: 10.1042/bj0590300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. VOGT M. Vasopressor, antidiuretic, and oxytocic activities of extracts of the dog's hypothalamus. Br J Pharmacol Chemother. 1953 Jun;8(2):193–196. doi: 10.1111/j.1476-5381.1953.tb00777.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weber C. J., Major R. H., Lobb D. THE PRODUCTION OF A PRESSOR SUBSTANCE FROM SERUM GLOBULIN BY ACTION OF PEPSIN. Science. 1942 Jul 10;96(2480):44–45. doi: 10.1126/science.96.2480.44. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES